The global neurosurgical products Market is witnessing significant growth due to growing geriatric population. Global Neurosurgical Products Market valued approximately USD 4.3 billion in 2020 is anticipated to grow with a healthy growth rate of more than 12.29% over the forecast period 2022-2031. Global Neurosurgical Products Market to reach USD 10.95 billion by 2031. “Final Report will add the analysis of the impact of COVID-19 on this industry.” Additionally, in the same year, the spending on health in high-income countries and in the low- and middle-income countries comprised approximately 8.2% and 6.3% of the GDP respectively. Moreover, the median health expenditure per capita recorded in the high-income, upper-middle income, and low & lower-middle income countries, recorded to be over USD 2,000, USD 400, and USD 100 respectively. The federal government commitment towards healthcare systems to enable market players expanding their revenues and mitigating the risk posed by the inflation. spent $12,318/person on healthcare- highest amongst all OECD countries followed by Germany at $7,383. to medical devices, pharma companies and biotech to benefit the market players in short and long term goals. remains committed to quality by spending more in the Medicaid and Medicare programs, incentives by govt. Healthcare Companies and Private Service Providers to have a minimal damage Caused by Inflation: As US govt. Factors like currency translation, disruption in global supply chain, Anti-China sentiments brewing across the globe, slowdown in Chinese economy, inflated products prices, USD getting stronger every week, decreasing purchasing power and strict measures taken by central banks/institutions across the world to ensure less spending and more saving, could hit the demand for the product and service badly in near future. The energy and gas crises has already started grappling the region, wherein many Western European countries including Germany is looking for coal fired solutions to tackle the gas supply shortage created by Russian-Ukraine conflict.Īmidst global concerns, market players have started looking for safe investments by holding on to the new technology and product launches. On the other hand, the worst is expected to be seen in the European countries, especially during 2022 winters. Global energy crises to remain at focal point impacting the economic activity in the U.S, pushing consumers to spend less on the products and services and save more. As mortgage rate touches highest at 6%, sales for houses declined for a sixth consecutive month. Apart from that, In July 2022, existing US home sales declined 5.9% to 4.81 million (seasonally adjusted annual rate), the lowest since May of 2020 and below market expectations of 4.89 million. Energy CPI surged by 32.9% in July 2022, inflating the cost of logistic and signs to disrupt supply chain whilst electricity cost upsurged by 15.2%, highest since Feb 2006. On the other hand, annual inflation rate in the country hit 8.5%. However, country’s goods and services deficit was $79.6 billion in June, down $5.3 billion from $84.9 billion in May, revised- reflecting some sight of relief.

Export of good and services increased by $25.7 billion to reach $1.03 trillion in the first quarter of 2022. However, in Q1 22, CAD rose by 29.6%, reached to $291.4 billion, adding $66.6 billion to the gap.

current-account deficit widened stood at $224.8 billion. Rise in incidences and prevalence of neurological conditions within the population and the advantage of neurosurgery over other conventional surgeries are expected to boost the growth of the neurosurgery devices market across the globe.ĭownload Sample of This Strategic Report-: Kenneth Research recently added a report on Neurosurgical Products Market which provides a detailed insight into the market scenario on the basis of the market size, market volume annual growth rate of the market over the forecast period, i.e., 2022-2031. Global Neurosurgical Products Market valued approximately USD 4.3 billion in 2020 is anticipated to grow with a healthy growth rate of more than 12.29% over the forecast period 2022-2031 . (a subsidiary of Johnson & Johnson), Stryker Corp, Integra Life sciences Corp, MicroVention Inc, Penumbra Inc, Cyberonicsin inc & Medtronic PLC.

Key Companies Covered in the Market Research are Boston Scientific Corp, DePuy Synthes Inc.

Hit radio antenne 1